Design, synthesis and bioactivity evaluation of tribactam β lactamase inhibitors
暂无分享,去创建一个
T. Šolmajer | T. Mesar | Mateja Vilar | Lovro Selič | B. Anžič | Anton Copar | T. Prevec
[1] J. Frère,et al. Kinetic Study of Two Novel Enantiomeric Tricyclic β-Lactams Which Efficiently Inactivate Class C β-Lactamases , 2001, Antimicrobial Agents and Chemotherapy.
[2] J. Frère,et al. Mechanistic diversity of beta-lactamases. , 1999, Biochemical Society transactions.
[3] J. Frère,et al. When drug inactivation renders the target irrelevant to antibiotic resistance: a case story with β‐lactams , 1999, Molecular microbiology.
[4] M. Page,et al. Structure-based design of beta-lactamase inhibitors. 1. Synthesis and evaluation of bridged monobactams. , 1998, Journal of medicinal chemistry.
[5] D. Livermore,et al. Interactions of β-Lactamases with Sanfetrinem (GV 104326) Compared to Those with Imipenem and with Oral β-Lactams , 1998, Antimicrobial Agents and Chemotherapy.
[6] R. Micetich,et al. SYN-1012: A New β-Lactamase Inhibitor of Penem Skeleton , 1997 .
[7] I. Massova,et al. MOLECULAR BASES FOR INTERACTIONS BETWEEN BETA -LACTAM ANTIBIOTICS AND BETA-LACTAMASES , 1997 .
[8] Alessandro Padova,et al. Synthesis of a novel fluoro-tribactam utilising an N-fluorosulfonimide in the key step , 1996 .
[9] S. Hanessian,et al. Tricyclic β-lactams: total synthesis and antibacterial activity of 5α- and 5β-methoxy-tribactams , 1995 .
[10] K. Coleman. Section Review: Anti-infectives: An update on β-lactamases and β-lactamase inhibitors , 1995 .
[11] G. Gaviraghi,et al. Synthesis and biological evaluation of 4-heterotribactams , 1995 .
[12] J. Frère,et al. Beta‐lactamases and bacterial resistance to antibiotics , 1995, Molecular microbiology.
[13] S. M. Hammond,et al. In vitro activity of the tribactam GV104326 against gram-positive, gram-negative, and anaerobic bacteria , 1994, Antimicrobial Agents and Chemotherapy.
[14] R. Volante,et al. A stereoselective synthesis of a key 1β-methylcarbapenem intermediate via a diastereoselective decarboxylation , 1994 .
[15] K. Bush,et al. Kinetic interactions of tazobactam with beta-lactamases from all major structural classes , 1993, Antimicrobial Agents and Chemotherapy.
[16] C. Sanders. beta-Lactamases of gram-negative bacteria: new challenges for new drugs. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] J. W. Page,et al. In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor , 1989, Antimicrobial Agents and Chemotherapy.
[18] A. Yoshida,et al. An Efficient Carbapenem Synthesis via an Intramolecular Wittig Reaction of New Trialkoxyphosphorane‐thiolesters. , 1984 .
[19] A. Bedeschi,et al. The carbonyl-carbonyl coupling route to penems : a stepwise analysis , 1984 .
[20] S. McCombie,et al. Homogeneous, palladium(0)-catalyzed exchange deprotection of allylic esters, carbonates and carbamates , 1982 .
[21] J. Inanaga,et al. Use of 1,8-diazabicyclo(5.4.0)undec-7-ene in preparation of trimethylsilyl enol ethers and trimethylsilylacetylenes. , 1981 .
[22] R. Woodward,et al. The penems, a new class of .beta.-lactam antibiotics. 3. Synthesis of optically active 2-methyl-(5R)-penem-3-carboxylic acid , 1979 .
[23] F. Westheimer,et al. Catalysis by molecular sieves in the preparation of ketimines and enamines , 1971 .